IP Library Granted Patent US 7,560,438
Granted Patent B2
US 7,560,438 · App. 10/283,190 · Granted Jul 14, 2009

Genetic inhibition by double-stranded RNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,560,438
App. No.
10/283,190
Granted
Jul 14, 2009
Kind
B2
Abstract

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Claims (25)

1. A method to inhibit expression of a target gene in a cell in a multicellular animal comprising providing at least one ribonucleic acid (RNA) to the cell in an amount sufficient to inhibit the expression of the target gene, wherein the RNA comprises or forms a double-stranded structure containing a first strand consisting essentially of a ribonucleotide sequence which corresponds to a nucleotide sequence of the target gene and a second strand consisting essentially of a ribonucleotide sequence which is complementary to the nucleotide sequence of the target gene, wherein the first and the second ribonucleotide sequences are separate complementary sequences that hybridize to each other to form said double-stranded structure, and the RNA comprising the double-stranded structure inhibits expression of the target gene, and wherein said animal is selected from the group consisting of worms and insects.

2. The method of claim 1 , wherein said multicellular animal has a digestive system, and wherein the RNA is provided to said animal by feeding said animal a second organism.

3. The method of claim 2 , wherein said second organism is engineered to produce said RNA from an expression construct.

4. A method to inhibit expression of a target gene in a cell in an animal comprising:

(a) isolating the cell from said animal;

(b) introducing an expression construct into said cell encoding an RNA comprising a double-stranded structure containing a first strand consisting essentially of a ribonucleotide sequence which corresponds to a nucleotide sequence of the target gene and a second strand consisting essentially of a ribonucleotide sequence which is complementary to the nucleotide sequence of the target gene, wherein the first and the second ribonucleotide sequences are separate sequences that hybridize to each other to form said double-stranded structure, and

(c) subsequently introducing said cell into said animal, wherein said RNA comprising the double-stranded structure inhibits expression of the target gene in said cell in said animal.

5. The method of claim 4 , wherein said cell is at risk for infection by a pathogen.

6. The method of claim 4 , wherein said cell is a human cell at risk for infection by a virus.

7. A method to inhibit expression of a target gene in a cell in an invertebrate animal comprising providing at least one ribonucleic acid (RNA) to the cell in an amount sufficient to inhibit the expression of the target gene, wherein said RNA is provided to the cell by synthesizing said RNA in said cell, wherein the RNA comprises or forms a double-stranded structure containing a first strand consisting essentially of a ribonucleotide sequence which corresponds to a nucleotide sequence of the target gene and a second strand consisting essentially of a ribonucleotide sequence which is complementary to the nucleotide sequence of the target gene, wherein the first and the second ribonucleotide sequences are complementary sequences that hybridize to each other to form said double-stranded structure and the RNA comprising the double-stranded structure inhibits expression of the target gene, and wherein the RNA is a double-stranded molecule containing two separate complementary RNA strands.

8. The method of claim 7 , wherein said RNA is provided to the cell by introducing an expression construct that synthesizes said RNA in said cell.

9. The method of claim 8 , wherein said invertebrate animal has a digestive system, and wherein said expression construct is orally administered to said animal such that the expression construct is introduced into the cell, thereby inhibiting expression of the target gene.

10. The method of claim 7 , wherein said invertebrate animal has a digestive system, and wherein the RNA is provided to said animal by feeding a second organism.

11. The method of claim 10 , wherein said second organism is engineered to produce said RNA from an expression construct.

12. A method to inhibit expression of a target gene in a cell comprising:

(a) isolating the cell from an animal;

(b) contacting the cell with at least one ribonucleic acid (RNA) comprising a double-stranded structure containing a first strand consisting essentially of a ribonucleotide sequence which corresponds to a nucleotide sequence of the target gene and a second strand consisting essentially of a ribonucleotide sequence which is complementary to the nucleotide sequence of the target gene, wherein the first and the second ribonucleotide sequences are separate sequences that hybridize to each other to form said double-stranded structure, and

(c) subsequently introducing said cell into said animal, wherein said RNA comprising the double-stranded structure inhibits expression of the target gene in said cell.

13. The method of claim 7 , wherein said invertebrate animal has a digestive system, and wherein a nucleic acid encoding said RNA is orally administered to said animal for synthesis of said RNA in the cell, thereby inhibiting expression of the target gene.

14. The method of claim 1 , wherein said RNA is provided to the cell by introducing an expression construct into said cell.

15. The method of claim 14 , wherein said expression construct is directly injected into said animal in the vicinity of said cell such that the construct is introduced into the cell, thereby inhibiting expression of the target gene.

16. The method of claim 14 , wherein said multicellular animal has a body cavity or interstitial space, and said expression construct is introduced into a body cavity or interstitial space of said animal such that the expression construct is introduced into the cell, thereby inhibiting expression of the target gene.

17. The method of claim 14 , wherein said multicellular animal has a digestive system, and wherein said expression construct is orally administered to said animal such that the expression construct is introduced into the cell, thereby inhibiting expression of the target gene.

18. The method of claim 1 wherein said worm is a nematode.

19. The method of claim 1 wherein said insect is Drosophila.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: FIRE, ANDREW; XU, SIQUN; MONTGOMERY, MARY K.; KOSTAS, STEPHEN A.; TIMMONS, LISA D.
To: THE CARNEGIE INSTITUTION OF WASHINGTON
Reel/Frame 042796/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2017
From: TABARA, HIROAKI; DRIVER, SAMUEL E.; MELLO, CRAIG C.
To: THE UNIVERSITY OF MASSACHUSETTS
Reel/Frame 042796/0197 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →
SECURITY AGREEMENT Recorded Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →